Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
06/14/1990 | WO1990006365A1 Recombinant proteins with adipsin and complement d activities |
06/14/1990 | WO1990006364A1 Drosophila receptors homologous to mammalian steroid receptors |
06/14/1990 | WO1990006358A1 Expression of hiv proteins in drosophila cells |
06/14/1990 | WO1990006321A1 Neutrophil-activating peptide-2 |
06/14/1990 | WO1990006318A1 Novel receptors: their identification, characterization, preparation and use |
06/14/1990 | WO1990006134A1 Human platelet-specific antibodies |
06/14/1990 | WO1990006133A1 Heterobifunctional antibodies having specificity for platelets and thrombolytic agents |
06/14/1990 | WO1990006047A2 Human high-affinity neurotransmitter uptake system |
06/13/1990 | EP0373012A1 DNA encoding for factor IX or an analogous protein |
06/13/1990 | EP0372707A2 Modified proteins, modified interferons, alphas and beta, phosphorylated proteins and analogues, DNA sequences, applications and uses thereof |
06/13/1990 | EP0372503A2 Anticoagulant peptides |
06/13/1990 | EP0372501A2 Synthetic antigens, method for their preparation and their use |
06/13/1990 | EP0372056A1 Protein micelles |
06/13/1990 | EP0372005A1 Expression systems for preparation of polypeptides in prokaryotic cells |
06/13/1990 | EP0140084B1 Process for the preparation of insulin derivatives with a c-terminally elongated b-chain, basically modified insulin derivatives, compositions containing them and their use |
06/13/1990 | CN1042940A Diagnostic reagent for identifying of serum antibody of poor and sick horse and horse inoculated with less toxic vaccine |
06/13/1990 | CA2005199A1 Genetically engineered endothelial cells and use thereof |
06/13/1990 | CA2003797A1 Nucleotides encoding human b1, 4-galactosyltransferase and uses thereof |
06/13/1990 | CA2002047A1 Serineprotease inhibitor proteins, pharmaceutical compositions containing them, dna sequences coding for these proteins and processes for the preparation of these proteins, pharmaceutical compositions and dna sequences |
06/12/1990 | US4933440 Immunomodulators obtained semisynthetically from a bacterial polysaccharide isolated from a non-encapsulated mutant strain of Klebsiella pneumoniae |
06/12/1990 | US4933434 Process for obtaining renatured proteins |
06/12/1990 | US4933433 Recombinant interleukin-2 composition and process for making it |
06/12/1990 | US4933294 Method of detecting truncated epidermal growth factor receptors |
06/12/1990 | US4933280 Treatment of respiratory deficiency syndrome |
06/12/1990 | US4933275 Method for the detection of a polypeptide subunit in the presence of a quaternary protein containing the subunit |
06/12/1990 | CA1270217A1 Recombinant plasmid provided with hepatitis b virus gene, yeast transformed with said recombinant plasmid, and production of hepatitis b virus surface antigen |
06/12/1990 | CA1270216A1 Processes for the preparation of obligate methylotrophic bacteria which express foreign dna, and plasmids and host organisms suitable for these |
06/08/1990 | CA2004935A1 Monoclonal antibodies to anti-interleukines-1 .alpha. and 1 .beta., process for their production and use of the antibodies for the detection of interleukines-1 .alpha. and 1-.beta. in therapeutics |
06/08/1990 | CA2004685A1 Neutrophil-activating peptide-2 |
06/07/1990 | CA2004810A1 Synthetic antigens, a process for the preparation thereof and the use thereof |
06/07/1990 | CA2004781A1 Products |
06/06/1990 | EP0371820A2 Novel receptors: their identification, characterization, preparation and use |
06/06/1990 | EP0371818A2 Peptides |
06/06/1990 | EP0371817A2 Peptides |
06/06/1990 | EP0371199A1 Novel protein H being capable of binding to IgG, gene coding for said protein H and a process for producing said protein H |
06/06/1990 | EP0371056A1 Methods and compositions for mimicking antigenic determinants |
06/06/1990 | EP0371046A1 Synthetic peptides related to hiv-env proteins |
06/06/1990 | EP0371041A1 A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation |
06/06/1990 | CN1042734A Monoclonal antibodies identifying alpha 2-3 linkage |
06/06/1990 | CA2004592A1 Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
06/05/1990 | US4931548 Heterodimer form of transforming growth factor-beta |
06/05/1990 | US4931395 Monoclonal antibody specific to neutrophils |
06/05/1990 | US4931390 Expression of the cloned lysostaphin gene |
06/05/1990 | US4931352 Antifungal fermentation product |
06/05/1990 | CA2004626A1 Derivatives of cyclosporine a, antibodies directed thereto and uses thereof |
06/05/1990 | CA1269930A1 Anticytomegalovirus monoclonal antibodies and processes for the in vitro diagnosis of infections by human cytomegaloviruses and of a protein-kinase inducible by cytomegaloviruses and which can be recognised by the abovesaid monoclonal antibodies |
06/01/1990 | CA2004288A1 Peptides |
06/01/1990 | CA2004287A1 Peptides |
06/01/1990 | CA2004261A1 Synthetic interleukin-6 |
05/31/1990 | WO1990005917A1 Pyruvate-kinase-isoenzyme-type-m2 (tumour m2-pk) specific antibodies, process for producing them and use |
05/31/1990 | WO1990005787A1 Position-specific insertion vectors and method of using same |
05/31/1990 | WO1990005786A1 Cloned genes which encode elam-1 and fusion proteins thereof, the protein products expressed therefrom, pharmaceutical compositions and the use thereof |
05/31/1990 | WO1990005785A1 Method for site-specifically incorporating unnatural amino acids into proteins |
05/31/1990 | WO1990005780A1 Dopamine receptors and genes |
05/31/1990 | WO1990005775A1 DNA ENCODING [Lys?46, Asp97, Asp113¿] AND [Lys?46, Asp113, Asp137¿] THAUMATIN I POLYPEPTIDES |
05/31/1990 | WO1990005748A1 Scavenger receptor protein and antibody thereto |
05/31/1990 | WO1990005746A1 Catalytic and reactive polypeptides and methods for their preparation and use |
05/31/1990 | WO1990005742A1 Fish crf |
05/31/1990 | WO1990005741A1 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
05/31/1990 | WO1990005740A1 Improved extraction methods for preparing thromboplastin reagents |
05/31/1990 | WO1990005737A1 Cloning and expression of a protein which modulates cellular response to type i interferon |
05/31/1990 | WO1990005540A1 Monoclonal antibodies specific for tumor antigens |
05/31/1990 | WO1990005539A1 Antibodies specific for elam-1 and the use thereof |
05/31/1990 | WO1990005538A1 Parvovirus capsids |
05/31/1990 | WO1990005530A1 Hybrid procoagulant proteins |
05/31/1990 | WO1990003435A3 Nucleic acid coding for the human angiotensine conversion enzyme (ace), and its applications particularly for the in vitro diagnosis of high blood pressure |
05/31/1990 | WO1990002803A3 Viral vaccines |
05/31/1990 | CA2004339A1 Novel receptors: their identification, characterization, preparation and use |
05/31/1990 | CA2003996A1 Model drosophila receptors |
05/30/1990 | EP0370989A2 Human vascular permeability factor |
05/30/1990 | EP0370768A2 Monoclonal antibody for the antigen specific to carcinoma of the thyroid |
05/30/1990 | EP0370581A1 Anti-hCG antibodies |
05/30/1990 | EP0370458A2 Synthetic DNA derived recombinant HIV-1 antigens |
05/30/1990 | EP0370399A2 Process for the preparation of tripeptides |
05/30/1990 | EP0370283A2 Process for preparing 63-carboxyamides of teicoplanin antibiotics |
05/30/1990 | EP0370256A1 Monoclonal antibody specifically recognizing sulfated glycolipids |
05/30/1990 | EP0370171A2 Human nerve growth factor |
05/30/1990 | EP0370163A1 Enzymatic purification process |
05/30/1990 | EP0370052A1 Human granulocyte-macrophage colony stimulating factor and muteins thereof |
05/30/1990 | EP0370036A1 MODIFIED FACTOR VII/VIIa. |
05/30/1990 | EP0370012A1 Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins |
05/29/1990 | US4929554 Human immune interferon |
05/29/1990 | US4929553 Protease for specific processing of secreted proteins |
05/29/1990 | US4929548 Antimicrobial peptides |
05/29/1990 | CA1269799A1 Method for extracting protein with organic acid |
05/25/1990 | CA2003773A1 Anti-hcg antibodies |
05/23/1990 | EP0369943A1 Binding protein for insulin-like growth factors |
05/23/1990 | EP0369877A1 Cloning and expression of a protein which modulates the cellular response to type I interferon |
05/23/1990 | EP0369861A2 Normal human growth regulatory receptor for TGF beta |
05/23/1990 | EP0369825A2 Streptolysin O antigen derivative, its production and uses |
05/23/1990 | EP0369816A2 Monoclonal antibodies specific for human polymorphic epithelial mucin |
05/23/1990 | EP0369797A2 A monoclonal antibody recognizing a reg protein |
05/23/1990 | EP0369664A2 Fish CRF |
05/23/1990 | EP0369567A2 Chimeric antibodies directed against metal chelates |
05/23/1990 | EP0369566A2 Bifunctional chimeric antibodies |
05/23/1990 | EP0369425A1 Monoclonal antibody specifically recognizing N-glycolyl type GM2, hybridoma producing the antibody and method for preparing the hybridoma |
05/23/1990 | EP0369413A2 Interferon-gamma binding proteins |
05/23/1990 | EP0369316A2 Recombinant interleukin-2 hybrid proteins |
05/23/1990 | EP0368920A1 Lectines fixing beta-d-galactoside. |
05/23/1990 | EP0368904A1 Purification of gm-csf |